Vontier price to free cash flow VNT

Market value divided by free cash flow over the last twelve months, since 2021.

Today, Oct 23, 2026: 12.1×
5-year median: 13.4×
Against its 5-year history: 30th; percentile: 0 is its lowest day, 100 its highest
5-year range: 8.1× to 17.7×
Peer median: 27.4×

Vontier's price to free cash flow is 12.1× as of Oct 23, 2026.

That is below its 5-year median of 13.4×, lower than on 70% of days in the last 5 years.

Over that time it ranged from 8.1× in Feb 2022 to 17.7× in Mar 2024.

The median for 10 medical instruments and supplies stocks of a similar size is 27.4×.

Price to free cash flow over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	12.1×	10.6×	14.7×
2025	13.4×	12.2×	16.9×
2024	15.9×	12.6×	17.7×
2023	13.0×	12.1×	17.0×
2022	13.8×	8.1×	14.7×
2021	10.2×	9.0×	11.2×

Against its peers

Companies in Medical - Instruments & Supplies nearest Vontier's size, closest first, today.

Company	Price to free cash flow
VNTVontier	12.1×
BMIBadger Meter	29.2×
ICUIICU Medical	27.3×
HAEHaemonetics	18.5×
MMSIMerit Medical Systems	27.4×
NVSTEnvista	15.3×
WRBYWarby Parker	147×
MSAMSA Safety	19.8×
ATRCAtriCure	56.5×
UFPTUFP Technologies	n/m
PODDInsulet	35.2×
Peer median	27.4×

What the price to free cash flow tells you

Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.

Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.

More on Vontier

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.